APPLICATION
ANDA207650
TYPE
ANDA
ORIGINAL APPROVAL
2017-09-29
LATEST ACTION
2025-02-24
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
CASPOFUNGIN ACETATEDiscontinued
CASPOFUNGIN ACETATE 70MG/VIAL · POWDER · INTRAVENOUS
CASPOFUNGIN ACETATEDiscontinued
CASPOFUNGIN ACETATE 50MG/VIAL · POWDER · INTRAVENOUS
Approval history
2025-02-24Labeling · Supplement 3 · standardAP
2025-02-24Labeling · Supplement 2 · standardAP
2017-09-29UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.